Оценка адекватности медицинской помощи при внебольничной пневмонии в стационарах различных регионов РФ: опыт использования индикаторов качества

Внебольничная пневмония , качество медицинской помощи , индикаторы качества

1. Jackson M.L., Neuzil K.M., Thompson W.W. et al. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin. Infect. Dis. 2004; 39: 1642-1650.

2. Agency for Healthcare Research and Quality. Pneumonia is the most common reason for hospitalization. Res. arch. 2008; 337: 25.

3. Статистические материалы «Заболеваемость населения России в 2006 году». ФГУ «Центральный научно-исследовательский институт организации и информатизации здравоохранения» Росздрава. Available from: http://www.minzdravsoc.ru/docs/mzsr/letters/60.

4. Российский статистический ежегодник - 2006. М.: ИИЦ «Cтатистика России»; 2007.

5. Niderman M.S., Mandell L.A., Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730-1754.

6. Mandell L.A., Wunderink R.G., Anzueto A. et al. IDSA / ATS Consensus Guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007; 44 (suppl. 2): S27-S72.

7. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26: 1138-1180.

8. British Thoracic Society guidelines for the management of community-acquired pneumonia in adults - 2004 update. Available from: www.brit-thoracic.org.uk

9. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике у взрослых / Чучалин А.Г., Синопальников А.И., Страчунский Л.С. и др. М.: Атмосфера; 2006.

10. Weingarten S. Assessing and improving quality of care. In: Williams S.J., Torrens P.R., eds. Introduction to health services. 6th ed. Thomson Learning, Inc.; 2002. 373-391.

11. Barlow G.D., Lamping D.L., Davey P.G., Nathwani D. Evaluation of outcomes in community-acquired pneumonia: a guide for patients, physicians and policy-makers. Lancet Infect. Dis. 2003; 3: 476-488.

12. Metersky M.L. Community-acquired pneumonia: process of care studies. Curr. Opin. Infect. Dis. 2002; 15: 169-174.

13. Внебольничная пневмония у взрослых: Практические рекомендации по диагностике, лечению и профилактике: Пособие для врачей / Чучалин А.Г., Синопальников А.И., Яковлев С.В. и др. М.; 2003.

14. Козлов С.Н., Рачина С.А., Домникова Н.П. и др. Фармакоэпидемиологический анализ лечения внебольничной пневмонии в амбулаторных условиях. Клин. микробиол. и антимикроб. химиотер. 2002; 2: 74-81.

15. Рачина С.А., Козлов С.Н., Андреева И.В. Фармакоэпидемиология антиинфекционных химиопрепаратов. В кн.: Страчунский Л.С., Белоусов Ю.Б., Козлов С.Н. (ред.). Практическое руководство по антиинфекционной химиотерапии. Смоленск: МАКМАХ; 2007. 47-55.

16. Garcia-Vazguez E., Marcos M.A., Mensa J. et al. Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system. Arch. Intern. Med. 2004; 164: 1807-1811.

17. van der Eerden M.M., Vlaspolder F., de Graaff C.S. et al. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study. Thorax 2005; 60: 672-678.

18. Musher D.M., Montoya R., Wanahita A. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin. infect. Dis. 2004; 39: 165-169.

19. Рачина С.А., Иванчик Н.В., Кречикова О.И. и др. Влияние предшествующей антибактериальной терапии на результативность микробиологических исследований при внебольничной пневмонии. Клин. микробиол. и антимикроб. химиотер. 2007; 9 (прил. 1): 35-36.

20. Campbell S.G., Marrie T.J., Anstey R., et al. The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study. Chest 2003; 123: 1142-1150.

21. Waterer G.W., Wunderink R.G. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir. Med. 2001; 95: 78-82.

22. Metersky M.L., Ma A., Bratzler D.W., Houck P.M. Predicting bacteremia in patients with community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 2004; 169: 342-347.

23. Meehan T.P., Fine M.J., Krumholz H.M., et al. Quality of care, process, and outcomes in elderly patients with pneumonia. J. A. M. A. 1997; 278: 2080-2084.

24. Battleman D.S., Callahan M., Thaler H.T. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch. Intern. Med. 2002; 162: 682-688.

25. Houck P.M., Bratzler D.W., Nsa W. et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch. Intern. Med. 2004; 164: 637-644.

26. Mortensen E.M., Restrepo M., Anzueto A., Pugh J. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am. J. Med. 2004; 117: 726-731.

27. Menendez R., Ferrando D., Valles J.M., Vallterra J. Influence of deviation from guidelines on the outcome of community-acquired pneumonia. Chest 2002; 122: 612-617.

28. Dean N.C., Silver M.P., Bateman K.A. et al. Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia. Am. J. Med. 2001; 110: 451-457.

29. Rhew D.C., Tu G.S., Ofman J. et al. Early switch and early discharge strategies in patients with community-acquired pneumonia: a meta-analysis. Arch. Intern. Med. 2001; 161: 722-727.

30. Halm E.A., Fine M.J., Marrie T.J. et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. J. A. M. A. 1998; 279: 1452-1457.

31. Ramirez J.A., Bordon J. Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia. Arch. Intern. Med. 2001; 161: 848-850.

32. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Mortal. Morbid. Wkly Rep. 1997; 46 (R-8).

33. Vila-Córcoles A., Ochoa-Gondar O., Hospital I., et al. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study. Clin. Infect. Dis. 2006; 43: 860-868.

34. Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Mortal. Morbid. Wkly Rep. Recomm. Rep. 2005; 54 (RR-8): 1-40.

35. Синопальников А.И. Внебольничная пневмония. В кн.: Синопальников А.И., Козлов Р.С.. Внебольничные инфекции дыхательных путей: Руководство для врачей. М.: Премьер МТ, Наш Город; 2007. 295-333.